GB201008541D0 - Diagnostic methods - Google Patents

Diagnostic methods

Info

Publication number
GB201008541D0
GB201008541D0 GBGB1008541.3A GB201008541A GB201008541D0 GB 201008541 D0 GB201008541 D0 GB 201008541D0 GB 201008541 A GB201008541 A GB 201008541A GB 201008541 D0 GB201008541 D0 GB 201008541D0
Authority
GB
United Kingdom
Prior art keywords
diagnostic methods
diagnostic
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1008541.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RECERCA INST DE RECERCA HOSPIT
Universite de Geneve
Fundacio Institut de Recerca Hospital Universitari Vall dHebron
Original Assignee
RECERCA INST DE RECERCA HOSPIT
Universite de Geneve
Fundacio Institut de Recerca Hospital Universitari Vall dHebron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RECERCA INST DE RECERCA HOSPIT, Universite de Geneve, Fundacio Institut de Recerca Hospital Universitari Vall dHebron filed Critical RECERCA INST DE RECERCA HOSPIT
Priority to GBGB1008541.3A priority Critical patent/GB201008541D0/en
Publication of GB201008541D0 publication Critical patent/GB201008541D0/en
Priority to PCT/GB2011/000784 priority patent/WO2011144914A2/en
Priority to AU2011254386A priority patent/AU2011254386B2/en
Priority to CA2800038A priority patent/CA2800038A1/en
Priority to EP11731457A priority patent/EP2572202A2/en
Priority to JP2013510677A priority patent/JP5775568B2/ja
Priority to US13/699,444 priority patent/US20130252834A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1088—Glutathione transferase (2.5.1.18)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
GBGB1008541.3A 2010-05-21 2010-05-21 Diagnostic methods Ceased GB201008541D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB1008541.3A GB201008541D0 (en) 2010-05-21 2010-05-21 Diagnostic methods
PCT/GB2011/000784 WO2011144914A2 (en) 2010-05-21 2011-05-23 Diagnostic methods
AU2011254386A AU2011254386B2 (en) 2010-05-21 2011-05-23 Diagnostic methods
CA2800038A CA2800038A1 (en) 2010-05-21 2011-05-23 Diagnostic methods
EP11731457A EP2572202A2 (en) 2010-05-21 2011-05-23 Diagnostic methods
JP2013510677A JP5775568B2 (ja) 2010-05-21 2011-05-23 診断方法
US13/699,444 US20130252834A1 (en) 2010-05-21 2011-05-23 Diagnostic Methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1008541.3A GB201008541D0 (en) 2010-05-21 2010-05-21 Diagnostic methods

Publications (1)

Publication Number Publication Date
GB201008541D0 true GB201008541D0 (en) 2010-07-07

Family

ID=42341144

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1008541.3A Ceased GB201008541D0 (en) 2010-05-21 2010-05-21 Diagnostic methods

Country Status (7)

Country Link
US (1) US20130252834A1 (enExample)
EP (1) EP2572202A2 (enExample)
JP (1) JP5775568B2 (enExample)
AU (1) AU2011254386B2 (enExample)
CA (1) CA2800038A1 (enExample)
GB (1) GB201008541D0 (enExample)
WO (1) WO2011144914A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012051519A2 (en) * 2010-10-14 2012-04-19 The Johns Hopkins University Biomarkers of brain injury
WO2012155134A2 (en) 2011-05-12 2012-11-15 The Johns Hopkins University Assay reagents for a neurogranin diagnostic kit
WO2013104720A2 (en) * 2012-01-12 2013-07-18 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Brain damage marker
JP6392202B2 (ja) 2012-03-13 2018-09-19 ザ・ジョンズ・ホプキンス・ユニバーシティ 脳損傷または神経変性のバイオマーカーとしてのシトルリン化脳および神経タンパク質
WO2015009907A1 (en) 2013-07-17 2015-01-22 The Johns Hopkins University A multi-protein biomarker assay for brain injury detection and outcome
CN103432574B (zh) * 2013-08-25 2015-04-08 浙江大学 一种过氧化物酶在制备防治脑血管疾病药物中的应用
EP3043891B1 (en) * 2013-09-13 2019-01-16 The Board of Trustees of The Leland Stanford Junior University Multiplexed imaging of tissues using mass tags and secondary ion mass spectrometry
CN107003317B (zh) * 2014-10-06 2019-04-19 日内瓦大学 生物标记及其在脑损伤中的应用
WO2017174557A2 (en) 2016-04-04 2017-10-12 Brains Online Holding B.V. Use of push pull microdialysis in combination with shotgun proteomics for analyzing the proteome in extracellular space of brain
WO2018148294A2 (en) * 2017-02-07 2018-08-16 Bioregency, Inc. S100β AND ISOFORMS FOR DETECTION OF NEUROLOGICAL CONDITIONS
CN107748263A (zh) * 2017-08-31 2018-03-02 北京臻惠康生物科技有限公司 一种纤维蛋白溶酶原的新用途及试剂盒
CN109536469B (zh) * 2018-11-23 2021-02-09 北华大学 突变改造Prx6蛋白及其表达基因、制备方法和应用
BR112022016169A2 (pt) * 2020-02-14 2022-10-25 Galaxy Ccro Inc Dispositivo de imunoensaios, método para determinar se um indivíduo sofre um acidente vascular cerebral ou ataque isquêmico, método para determinar o status atual e/ou a probabilidade de progressão para doença grave, método para determinar se um indivíduo sofreu uma lesão, método para monitorar o efeito do tratamento, kit

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
CA2263063C (en) * 1999-02-26 2004-08-10 Skye Pharmatech Incorporated Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
CA2532130C (en) * 2003-09-20 2016-07-19 Electrophoretics Limited Diagnostic method for brain damage-related disorders
US20080307537A1 (en) * 2005-03-31 2008-12-11 Dana-Farber Cancer Institute, Inc. Compositions and Methods for the Identification, Assessment, Prevention, and Therapy of Neurological Diseases, Disorders and Conditions
JP4521512B2 (ja) * 2005-06-15 2010-08-11 独立行政法人産業技術総合研究所 痴呆症の診断方法及び診断キット
GB2428240A (en) * 2005-07-14 2007-01-24 Univ Gen Ve Diagnostic method for brain damage-related disorders
WO2008021290A2 (en) * 2006-08-09 2008-02-21 Homestead Clinical Corporation Organ-specific proteins and methods of their use

Also Published As

Publication number Publication date
EP2572202A2 (en) 2013-03-27
JP5775568B2 (ja) 2015-09-09
CA2800038A1 (en) 2011-11-24
AU2011254386B2 (en) 2017-01-12
WO2011144914A2 (en) 2011-11-24
WO2011144914A3 (en) 2012-03-29
US20130252834A1 (en) 2013-09-26
JP2013531784A (ja) 2013-08-08
AU2011254386A1 (en) 2012-12-06

Similar Documents

Publication Publication Date Title
AP3107A (en) 5-Alkynyl-pyrimidines
GB201010196D0 (en) Methods
ZA201304196B (en) Diagnostic system
SG184797A1 (en) Q tomography method
EP2514352A4 (en) Borescope
EP2476362A4 (en) Borescope
GB201008541D0 (en) Diagnostic methods
EP2561795A4 (en) PROBE
GB2498491B (en) Diagnostic system
GB201007075D0 (en) Diagnostic reagents
PL2361544T3 (pl) Endoskop
GB201008719D0 (en) Diagnostic method
GB201007944D0 (en) Methods
GB201011420D0 (en) Method for diagnosis
GB201005624D0 (en) Probe
GB201016161D0 (en) Diagnostic method
ZA201301498B (en) Diagnostic method
EP2633796A4 (en) PROBE
GB201002409D0 (en) Methods
GB201016346D0 (en) Connection means
GB201012072D0 (en) Diagnostic reagents
EP2653090A4 (en) PROBE
GB201011367D0 (en) Methods
EP2522269A4 (en) PROBE
GB201010960D0 (en) Complex

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)